No Data
Bloomage BioTechnology Corporation Limited (SHSE:688363) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
Open Source Securities: Blue Ocean of Collagen Medical Beauty Market Awaits Exploration, and High-end Consumer Group Leads the Trend.
In 2023, the penetration rate of recombined collagen protein medical beauty products is expected to be less than 20% among high-end consumers, but Open Source Securities believes that its differentiated benefits such as anti-aging around the eyes and improving facial fine lines have the potential to seize the budget of competing products.
Bloomage Biotechnology Corporation Limited (688363.SH): Accrued repurchase of 0.6883% of the company's shares.
On August 29, GeLongHui reported that as of August 28, 2024, Bloomage Biotechnology Corporation Limited (688363.SH) has repurchased a total of 3,315,538 shares, accounting for 0.6883% of the total share capital of 481,678,242 shares. The highest repurchase price was 89.71 yuan per share, the lowest price was 56.37 yuan per share, and the total amount paid was RMB 219,947,377.83 (excluding stamp duty, transaction commission, and other transaction fees).
Earnings Miss: Bloomage BioTechnology Corporation Limited Missed EPS By 69% And Analysts Are Revising Their Forecasts
The performance has "double declined" and the stock price "continues to fall". Why did bloomage biotechnology corporation limited's growth engine stall?
① Bloomage Biotechnology Corporation Limited once again experienced a double decline in revenue and net income in the first half of the year. The company achieved revenue of 2.81 billion yuan, a year-on-year decrease of 8.61%; achieved net income of 0.342 billion yuan, a year-on-year decrease of 19.51%; ② Although the raw materials business and medical terminal business performed well, the two major new sectors that have been heavily promoted in recent years - functional skincare products and functional food - have experienced a simultaneous decline in growth rates.
Bloomage Biotechnology Corporation Limited 2024 Semi-Annual Report
Bloomage BioTechnology Corporation Limited's (SHSE:688363) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
No Data
No Data
